Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
Recruiting · NCT06864403 · Registry updated 2026-01-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch | Crohn ileitis, Digestive System Diseases, Ileal Diseases, digestive system disorder, enteritis, gastroenteritis, intestinal disorder, pouchitis | Recruiting | Phase 4 | 2026-01-30 | NCT06864403 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eli Lilly and Company | 370 |
| University of North Carolina, Chapel Hill | 249 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Allegheny Health Network | Pittsburgh | United States | 35 |
| Mayo Clinic | Rochester | United States | 664 |
| NYU Langone Health | New York | United States | 403 |
| UCLA Vatche & Tamar Manoukian Division of Digestive Diseases | Los Angeles | United States | 1 |
| University of North Carolina | Chapel Hill | United States | 4 |